Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (21-30 of 331) with videos related to

Pageof 34
Sort By:
Hematology/Oncology Clinics of North America|June 27, 2023
Adjuvant and Neoadjuvant Therapy in Renal Cell CarcinomaTeele Kuusk, Axel Bex
European Urology|May 27, 2020
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled TrialTeele Kuusk, Axel Bex
Nature Reviews. Nephrology|July 6, 2018
The role of nephrectomy in metastatic renal cell carcinomaViktor Grünwald, Axel Bex
European Urology Open Science|September 8, 2022
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: ConTeele Kuusk, Axel Bex
European Urology Open Science|January 17, 2022
Cytoreductive Nephrectomy: Still Necessary in 2021Arnaud Méjean, Axel Bex
European Urology|May 17, 2021
Radical Nephrectomy: The Widening Gap Between Evolution of Technique and EvidenceBörje Ljungberg, Axel Bex
Lancet (London, England)|November 8, 2011
Tilting the AXIS towards therapeutic limits in renal cancerAxel Bex, John Haanen
European Urology|January 22, 2017
Re: Detection of Micrometastases by Flow Cytometry in Sentinel Lymph Nodes from Patients with Renal TumoursTeele Kuusk, Axel Bex
Expert Review of Anticancer Therapy|June 22, 2012
Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and whenAxel Bex, Tom Powles
Nature Reviews. Clinical Oncology|July 4, 2018
Cytoreductive nephrectomy in metastatic renal cancer - less is moreAxel Bex, John Haanen
Pageof 34

Showing results (21-30 of 331) with videos related to

Sort By:
Pageof 34
Hematology/Oncology Clinics of North America|June 27, 2023
Adjuvant and Neoadjuvant Therapy in Renal Cell CarcinomaTeele Kuusk, Axel Bex
European Urology|May 27, 2020
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled TrialTeele Kuusk, Axel Bex
Nature Reviews. Nephrology|July 6, 2018
The role of nephrectomy in metastatic renal cell carcinomaViktor Grünwald, Axel Bex
European Urology Open Science|September 8, 2022
Partial Nephrectomy for Metastatic Renal Cell Carcinoma: ConTeele Kuusk, Axel Bex
European Urology Open Science|January 17, 2022
Cytoreductive Nephrectomy: Still Necessary in 2021Arnaud Méjean, Axel Bex
European Urology|May 17, 2021
Radical Nephrectomy: The Widening Gap Between Evolution of Technique and EvidenceBörje Ljungberg, Axel Bex
Lancet (London, England)|November 8, 2011
Tilting the AXIS towards therapeutic limits in renal cancerAxel Bex, John Haanen
European Urology|January 22, 2017
Re: Detection of Micrometastases by Flow Cytometry in Sentinel Lymph Nodes from Patients with Renal TumoursTeele Kuusk, Axel Bex
Expert Review of Anticancer Therapy|June 22, 2012
Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and whenAxel Bex, Tom Powles
Nature Reviews. Clinical Oncology|July 4, 2018
Cytoreductive nephrectomy in metastatic renal cancer - less is moreAxel Bex, John Haanen
Pageof 34